insights_auto
Prečo akcie BRM stúpli 5,53%?
Preskúmať podrobnejšiechevron_right
BRM:FRA
Bristol-Myers Squibb Co
54,38 €
arrow_upward
+5,53%(+2,85) 1 d.
15. 10., 15:43:49 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BRM…
Otvoriť
53,05 €
Vysoká
54,38 €
Nízka
53,05 €
Trh. kap.
124,52 mld.
Priem. obj.
230,00
Objem
0,00
Max. za 52 týž.
60,64 €
Min. za 52 týž.
36,65 €
Počet zamestnancov
32 tis.
Otvoriť
53,05 €
Vysoká
54,38 €
Nízka
53,05 €
Trh. kap.
124,52 mld.
Priem. obj.
230,00
Objem
0,00
Max. za 52 týž.
60,64 €
Min. za 52 týž.
36,65 €
Počet zamestnancov
32 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
MarketBeat
·
pred 1 hodinou
31,005 Bristol Myers Squibb Company $BMY Shares Sold by Chiron Capital Management LLC
Bloomberg Government News
·
pred 2 hodinami
Bristol, AbbVie Seek Intervention in Suit Over Drug Rebate Pilot
Yahoo Finance
·
pred 2 hodinami
Bristol-Myers Squibb's Pulmonary Fibrosis Treatment Still Viable Despite Recent Mixed Phase 3 Results, UBS Says
Simply Wall Street
·
pred 3 hodinami
Mixed Trial Results Might Change The Case For Investing In Bristol Myers Squibb (BMY)
Profil
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Informácie o subjekte Bristol-Myers Squibb Co
Generálny riaditeľChris Boerner
Zamestnanci32,5 tis.
Dátum založenia1887
Hlavné sídloNew York, New York, Spojené štáty americké
Odvetvie-
Webbms.com